Correlation Between Aceragen and Armata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aceragen and Armata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aceragen and Armata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aceragen and Armata Pharmaceuticals, you can compare the effects of market volatilities on Aceragen and Armata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aceragen with a short position of Armata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aceragen and Armata Pharmaceuticals.
Diversification Opportunities for Aceragen and Armata Pharmaceuticals
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aceragen and Armata is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Aceragen and Armata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armata Pharmaceuticals and Aceragen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aceragen are associated (or correlated) with Armata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armata Pharmaceuticals has no effect on the direction of Aceragen i.e., Aceragen and Armata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aceragen and Armata Pharmaceuticals
If you would invest 240.00 in Armata Pharmaceuticals on September 3, 2024 and sell it today you would lose (10.00) from holding Armata Pharmaceuticals or give up 4.17% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
Aceragen vs. Armata Pharmaceuticals
Performance |
Timeline |
Aceragen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Armata Pharmaceuticals |
Aceragen and Armata Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aceragen and Armata Pharmaceuticals
The main advantage of trading using opposite Aceragen and Armata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aceragen position performs unexpectedly, Armata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will offset losses from the drop in Armata Pharmaceuticals' long position.Aceragen vs. Addex Therapeutics | Aceragen vs. Soligenix | Aceragen vs. Avenue Therapeutics | Aceragen vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |